GlycoBac LLC is a specialized pharmaceutical manufacturing company located in Laramie, Wyoming, focused on advanced biotechnology solutions and drug development services. The company operates at the intersection of glycobiology and bacterial expression systems, providing innovative manufacturing capabilities for pharmaceutical clients seeking high-quality biologic products.
The company specializes in bacterial fermentation processes and glycoprotein production technologies, offering contract manufacturing services for pharmaceutical and biotechnology companies. GlycoBac leverages advanced bacterial expression platforms to produce complex biologics, including therapeutic proteins and vaccines, with enhanced glycosylation profiles that improve drug efficacy and stability.
Located in Wyoming, GlycoBac benefits from a strategic position that combines access to skilled scientific talent with cost-effective operations. The facility maintains rigorous quality control standards and regulatory compliance protocols essential for pharmaceutical manufacturing operations. The company serves as a trusted partner for drug development programs, offering scalable production solutions from research quantities through commercial manufacturing volumes.
GlycoBac focuses on delivering customized manufacturing solutions that meet specific client requirements while maintaining the highest standards of product quality and regulatory compliance. Their expertise in bacterial glycoengineering and fermentation technology positions them as a valuable partner for pharmaceutical companies developing next-generation biologic therapeutics requiring specialized manufacturing capabilities and technical expertise.
Specialties: Baculovirus Expression SystemsVaccine ManufacturingBiologics Production +1 more
Processes: Cell CultureProtein Expression +2 more